Companies: 10,795·Total market cap: $144.5T

HeartSciences Inc.

HeartSciences Inc.

HSCSNASDAQHealthcare● Active

$1.84

$-0.10(-5.15%)

Market Cap$3987740

P/E Ratio—

52W High$6.47

52W Low$1.63

Avg Volume24K

Open$1.88

Beta1.97

Net Income Financials Revenue

HeartSciences Inc. (HSCS) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

HSCS · net income · updated Jun 8, 2026

Core profitability metrics

HSCS · net income · margin · TTM · CAGR

Net income was −$8.8M for FY2025 (fiscal year ending 2025-04-30), down 32.7% year-over-year. Net profit margin was -201499.5%.

FY2025 Net Income−$8.8M▼ -32.7% YoY

Trailing 12M (TTM)−$8.5Mtrailing 4 quarters sum

Net Profit Margin< −999%−$8.8M ÷ $4,350

YoY Change-32.7%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · HSCS net income history · HSCS profit margin

Annual net income data

HSCS · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$8.8M▼ 32.7%-201499.5%$4,350

FY2024Loss−$6.6M▼ 3.9%-35511.9%$18,600

FY2023Loss−$6.4M▼ 31.6%-123384.3%$5,150

FY2022Loss−$4.8M▼ 96.9%-33592.6%$14,373

FY2021Loss−$2.5M▲ +35.7%-9577.3%$25,604

Net income vs peers (Healthcare)

HSCS vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

#1

HeartSciences Inc.YOU

HSCS

−$8.8M-32.7%-201499.5%

Loss

Johnson & Johnson

$26.80B+90.6%28.5%

Eli Lilly and Company

$20.64B+94.9%31.7%

UnitedHealth Group Incorporated

$12.06B-16.3%2.7%

$4.23B-1.2%6.9%

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

HeartSciences Inc. (HSCS) reported net income of −$8.8M for FY2025 (fiscal year ending 2025-04-30), down 32.7% year-over-year. The net profit margin was -201499.5% — meaning the company kept $-2015.00 of every dollar of revenue as profit.

HeartSciences Inc. has not yet achieved annual profitability based on available data (6 fiscal years). The company has reported net losses across all available periods.

HeartSciences Inc.'s net profit margin was -201499.5% for FY2025, based on the latest annual results.

Investors sometimes search for "HeartSciences Inc. net worth" — the company's market capitalization is a separate figure from HSCS net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

HSCS net income · 4 questions

HeartSciences Inc. is not currently profitable on an annual basis. The company reported a net loss of $8.8M for FY2025.

is HSCS profitabledoes HSCS make a profitHSCS profitabilityHSCS profitable company

▸ Source: FMP /income-statement · GAAP · HeartSciences Inc. · HeartSciences Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026